Kidney-specific methylation patterns correlate with kidney function and are lost upon kidney disease progression

被引:1
|
作者
Sagy, Naor [1 ]
Meyrom, Noa [1 ]
Beckerman, Pazit [2 ,3 ]
Pleniceanu, Oren [2 ,3 ]
Bar, Daniel Z. [1 ,4 ]
机构
[1] Tel Aviv Univ, Goldschleger Sch Dent Med, Fac Med & Hlth Sci, Dept Oral Biol, IL-69978 Tel Aviv, Israel
[2] Sheba Med Ctr, Inst Nephrol & Hypertens, Kidney Res Lab, Tel Hashomer, Israel
[3] Tel Aviv Univ, Fac Med & Hlth Sci, Tel Aviv, Israel
[4] Tel Aviv Univ, AI & Data Sci Ctr TAD, IL-69978 Tel Aviv, Israel
基金
以色列科学基金会;
关键词
DNA METHYLATION; BASE-LINE; FIBROSIS; HYPERMETHYLATION; ASSOCIATION; BIOPSY; CANCER; CELLS; RISK; TIME;
D O I
10.1186/s13148-024-01642-w
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundChronological and biological age correlate with DNA methylation levels at specific sites in the genome. Linear combinations of multiple methylation sites, termed epigenetic clocks, can inform us the chronological age and predict multiple health-related outcomes. However, why some sites correlating with lifespan, healthspan, or specific medical conditions remain poorly understood. Kidney fibrosis is the common pathway for chronic kidney disease, which affects 10% of European and US populations.ResultsHere we identify epigenetic clocks and methylation sites that correlate with kidney function. Moreover, we identify methylation sites that have a unique methylation signature in the kidney. Methylation levels in majority of these sites correlate with kidney state and function. When kidney function deteriorates, all of these sites regress toward the common methylation pattern observed in other tissues. Interestingly, while the majority of sites are less methylated in the kidney and become more methylated with loss of function, a fraction of the sites are highly methylated in the kidney and become less methylated when kidney function declines. These methylation sites are enriched for specific transcription-factor binding sites. In a large subset of sites, changes in methylation patterns are accompanied by changes in gene expression in kidneys of chronic kidney disease patients.ConclusionsThese results support the information theory of aging, and the hypothesis that the unique tissue identity, as captured by methylation patterns, is lost as tissue function declines. However, this information loss is not random, but guided toward a baseline that is dependent on the genomic loci.Significance statementDNA methylation at specific sites accurately reflects chronological and biological age. We identify sites that have a unique methylation pattern in the kidney. Methylation levels in the majority of these sites correlate with kidney state and function. Moreover, when kidney function deteriorates, all of these sites regress toward the common methylation pattern observed in other tissues. Thus, the unique methylation signature of the kidney is degraded, and epigenetic information is lost, when kidney disease progresses. These methylation sites are enriched for specific and methylation-sensitive transcription-factor binding sites, and associated genes show disease-dependent changes in expression. These results support the information theory of aging, and the hypothesis that the unique tissue identity, as captured by methylation patterns, is lost as tissue function declines.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Kidney-specific methylation patterns correlate with kidney function and are lost upon kidney disease progression
    Naor Sagy
    Noa Meyrom
    Pazit Beckerman
    Oren Pleniceanu
    Daniel Z. Bar
    [J]. Clinical Epigenetics, 16
  • [2] DNA methylation markers for kidney function and progression of diabetic kidney disease
    Li, Kelly Yichen
    Tam, Claudia Ha Ting
    Liu, Hongbo
    Day, Samantha
    Lim, Cadmon King Poo
    So, Wing Yee
    Huang, Chuiguo
    Jiang, Guozhi
    Shi, Mai
    Lee, Heung Man
    Lan, Hui-yao
    Szeto, Cheuk-Chun L.
    Hanson, Robert L. G.
    Nelson, Robert G.
    Susztak, Katalin
    Chan, Juliana C. N. Y.
    Yip, Kevin Y.
    Ma, Ronald C. W.
    [J]. NATURE COMMUNICATIONS, 2023, 14 (01)
  • [3] DNA methylation markers for kidney function and progression of diabetic kidney disease
    Kelly Yichen Li
    Claudia Ha Ting Tam
    Hongbo Liu
    Samantha Day
    Cadmon King Poo Lim
    Wing Yee So
    Chuiguo Huang
    Guozhi Jiang
    Mai Shi
    Heung Man Lee
    Hui-yao Lan
    Cheuk-Chun Szeto
    Robert L. Hanson
    Robert G. Nelson
    Katalin Susztak
    Juliana C. N. Chan
    Kevin Y. Yip
    Ronald C. W. Ma
    [J]. Nature Communications, 14
  • [4] Promising novel therapeutic targets for kidney disease: Emphasis on kidney-specific proteins
    Sen, Tathambika Tejeswini
    Kale, Ajinath
    Lech, Maciej
    Anders, Hans-Joachim
    Gaikwad, Anil Bhanudas
    [J]. DRUG DISCOVERY TODAY, 2023, 28 (02) : 1 - 10
  • [5] Promoter methylation confers kidney-specific expression of the Klotho gene
    Azuma, Masahiro
    Koyama, Daisuke
    Kikuchi, Jiro
    Yoshizawa, Hiromichi
    Thasinas, Dissayabutra
    Shiizaki, Kazuhiro
    Kuro-o, Makoto
    Furukawa, Yusuke
    Kusano, Eiji
    [J]. FASEB JOURNAL, 2012, 26 (10): : 4264 - 4274
  • [6] Kidney-specific gene targeting
    Igarashi, P
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (08): : 2237 - 2239
  • [7] Arterial Stiffness, Kidney Function, and Chronic Kidney Disease Progression
    Townsend, Raymond R.
    Tomiyama, Hirofumi
    [J]. PULSE, 2013, 1 (02) : 123 - 130
  • [8] Kidney-specific overexpression of VEGF-A.
    Sood, MM
    Eremina, V
    Quaggin, SE
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 301A - 301A
  • [9] PHYSICOCHEMICAL PROPERTIES OF KIDNEY-SPECIFIC ANTIGEN
    AVERKINA, RF
    [J]. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 1984, 97 (01) : 82 - 85
  • [10] The Kidney-specific Psychosocial ASSessment and support (Kidney PASSPORT) feasibility trial
    Hamilton, Alexander
    Bell, Rebecca
    Strickland, Sam
    Pike, Karen
    Farrand, Paul
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1184 - I1185